SCHMC

Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer

Metadata Downloads
Abstract
The clinical course from recurrence to cancer-related death after curative resection has not been clearly elucidated in non-small-cell lung cancer (NSCLC). This study examined the clinical outcomes after postoperative recurrence in patients with completely resected Stage I NSCLC. This study included patients who had recurrence after complete resection for pathological Stage I NSCLC between 2003 and 2009. Clinical data evaluated in this study included the diagnostic process of recurrence, recurrence pattern, treatment process and prognosis. A number of clinicopathological factors were analysed for post-recurrence survival by univariate and multivariate analyses. Seventy-two patients experienced recurrence during a median follow-up period of 37.5 months. Thirteen patients (18%) presented symptoms at the initial recurrence. Tumour markers, computed tomography (CT) and positron emission tomography/CT were chosen as the initial diagnostic tools and detected recurrences in 1 (1%), 51 (71%) and 7 (10%) patients, respectively. The mean recurrence-free interval (RFI) was 15.4 months (< 12 months in 34, > 12 months in 38 patients). The patterns of recurrence were presented as loco-regional recurrence in 36 (50%) and distant metastasis in 36 patients (50%). Types of the initial treatment included operations in 28 (39%), chemotherapy and/or radiotherapy in 38 (53%) and radiofrequency ablation in 2 patients (3%). Four patients (6%) rejected treatment. Forty-three patients (62%) presented a good response to the initial treatment. Thirty-seven patients (51%) died, and the cause of death in all of these patients was cancer-related. The median survival duration after recurrence was 43.6 (1-136) months. Univariate analysis identified no recurrence of symptoms, a good response to treatment and a longer RFI as good prognostic factors, while a good response to treatment and a longer RFI were independent prognostic factors in multivariate analysis. Most postoperative recurrences were detected in an asymptomatic condition during the routine follow-up period, and a good response to initial treatment and a longer RFI were significant predictors of better post-recurrence survival in patients with completely resected Stage I NSCLC.
All Author(s)
I. H. Song ; S. W. Yeom ; S. Heo ; W. S. Choi ; H. C. Yang ; S. Jheon ; K. Kim ; S. Cho
Issued Date
2014
Type
Article
Keyword
Non-small-cell lung cancerStage IRecurrencePost-recurrence survival
Publisher
European Association for Cardio-thoracic Surgery
ISSN
1010-7940
Citation Title
European Journal of Cardio-Thoracic Surgery
Citation Volume
45
Citation Number
2
Citation Start Page
262
Citation End Page
267
Language(ISO)
eng
DOI
10.1093/ejcts/ezt333
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/2650
Appears in Collections:
심장혈관흉부외과 > 1. Journal Papers
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.